Calcitriol-mediated hypercalcemia as an immune-related adverse event in a patient receiving nivolumab and ipilimumab for metastatic renal cell carcinoma, case report

BACKGROUND: Severe hypercalcemia is often associated with uncontrolled malignancy through several mechanisms. However, calcitriol-mediated hypercalcemia is a rare etiology for advanced solid tumors. CASE PRESENTATION: We report a case of calcitriol-mediated hypercalcemia secondary to immune checkpoi...

Descripción completa

Detalles Bibliográficos
Autores principales: Johnson, Kai, Issa, Majd, Parikh, Anish, Monk, Paul, Yin, Ming, Mortazavi, Amir, Yang, Yuanquan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8017871/
https://www.ncbi.nlm.nih.gov/pubmed/33794867
http://dx.doi.org/10.1186/s12894-021-00825-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8017871/
https://www.ncbi.nlm.nih.gov/pubmed/33794867
http://dx.doi.org/10.1186/s12894-021-00825-4

Ejemplares similares